These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27965522)

  • 1. Corrigendum to "Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease".
    Phillips-Farfán B; Carvajal K; Medina-Torres EA; Espinosa-Padilla SE; Fabrias G; Camacho L
    Mediators Inflamm; 2016; 2016():7267956. PubMed ID: 27965522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease.
    Bryan PF; Karla C; Edgar Alejandro MT; Sara Elva EP; Gemma F; Luz C
    Mediators Inflamm; 2016; 2016():9890141. PubMed ID: 27656050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum: Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer.
    Ma Y; Zhang Y; Jiang H; Xiang S; Zhao Y; Xiao M; Du F; Ji H; Kaboli PJ; Wu X; Li M; Wen Q; Shen J; Yang Z; Li J; Xiao Z
    Front Cell Infect Microbiol; 2021; 11():765843. PubMed ID: 34646786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: How Early-Life Gut Microbiota Alteration Sets Trajectories for Health and Inflammatory Bowel Disease?
    Guo F; Cai D; Li Y; Gu H; Qu H; Zong Q; Bao W; Chen A; Liu HY
    Front Nutr; 2021; 8():760443. PubMed ID: 34604289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between the intestinal microbiota and the innate immune system in intestinal homeostasis and inflammatory bowel disease.
    Dupaul-Chicoine J; Dagenais M; Saleh M
    Inflamm Bowel Dis; 2013 Sep; 19(10):2227-37. PubMed ID: 23669404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fostering Inflammatory Bowel Disease: Sphingolipid Strategies to Join Forces.
    Abdel Hadi L; Di Vito C; Riboni L
    Mediators Inflamm; 2016; 2016():3827684. PubMed ID: 26880864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingolipids in neutrophil function and inflammatory responses: Mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis.
    Espaillat MP; Kew RR; Obeid LM
    Adv Biol Regul; 2017 Jan; 63():140-155. PubMed ID: 27866974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: New Insights and Advances in Pathogenesis and Treatment of Very Early Onset Inflammatory Bowel Disease.
    Li QQ; Zhang HH; Dai SX
    Front Pediatr; 2022; 10():894682. PubMed ID: 35633960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-Gut Microbiota Crosstalk in Intestinal Adaptation.
    Marchix J; Goddard G; Helmrath MA
    Cell Mol Gastroenterol Hepatol; 2018; 6(2):149-162. PubMed ID: 30023411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum: 2016 ACG Abstracts-Inflammatory Bowel Disease.
    Osterman M; Gastonguay MR; Lasch K; Barocas MA; Rosario M; Wilbur JD; Dirks NL
    Am J Gastroenterol; 2017 Jul; 112(7):1209-1210. PubMed ID: 28071657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum: ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.
    Farraye FA; Melmed GY; Lichtenstein GR; Kane SV
    Am J Gastroenterol; 2017 Jul; 112(7):1208. PubMed ID: 28534523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microbiome and its implications in intestinal transplantation.
    Kroemer A; Elsabbagh AM; Matsumoto CS; Zasloff M; Fishbein TM
    Curr Opin Organ Transplant; 2016 Apr; 21(2):135-9. PubMed ID: 26761420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum to "Low Body Mass Index Can Identify Majority of Osteoporotic Inflammatory Bowel Disease Patients Missed by Current Guidelines".
    Atreja A; Aggarwal A; Licata AA; Lashner BA
    ScientificWorldJournal; 2017; 2017():3937676. PubMed ID: 28884142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: Impact of intestinal microbiota on metabolic toxicity and potential detoxification of amygdalin.
    Wen Q; Yu S; Wang S; Qin Y; Xia Q; Wang S; Chen G; Shen C; Song S
    Front Microbiol; 2023; 14():1303273. PubMed ID: 38029160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: Combined intestinal metabolomics and microbiota analysis for acute endometritis induced by lipopolysaccharide in mice.
    Dong Y; Yuan Y; Ma Y; Luo Y; Zhou W; Deng X; Pu J; Hu B; Liu S
    Front Cell Infect Microbiol; 2023; 13():1223663. PubMed ID: 37360533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: Rural and Urban Residence During Early Life Is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study.
    Benchimol EI; Kaplan GG; Otley AR; Nguyen GC; Underwood FE; Guttmann A; Jones JL; Potter BK; Catley CA; Nugent ZJ; Cui Y; Tanyingoh D; Mojaverian N; Bitton A; Carroll MW; deBruyn J; Dummer TJB; El-Matary W; Griffiths AM; Jacobson K; Kuenzig ME; Leddin D; Lix LM; Mack DR; Murthy SK; Sánchez JNP; Singh H; Targownik LE; Vutcovici M; Bernstein CN
    Am J Gastroenterol; 2017 Sep; 112(9):1485. PubMed ID: 28874854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: Immunological Impact of Intestinal T Cells on Metabolic Diseases.
    Zhou H; Wang L; Liu F
    Front Immunol; 2021; 12():682376. PubMed ID: 33936121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum to: Effects of Arthrocen, an avocado/soy unsaponifiables agent, on inflammatory mediators and gene expression in human chondrocytes.
    FEBS Open Bio; 2018 Aug; 8(8):1364. PubMed ID: 30087838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary and Endogenous Sphingolipid Metabolism in Chronic Inflammation.
    Norris GH; Blesso CN
    Nutrients; 2017 Oct; 9(11):. PubMed ID: 29143791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum to "Long-Term Potable Effects of Alkalescent Mineral Water on Intestinal Microbiota Shift and Physical Conditioning".
    Yahiro T; Hara T; Matsumoto T; Ikebe E; Fife-Koshinomi N; Xu Z; Hiratsuka T; Iha H; Inomata M
    Evid Based Complement Alternat Med; 2020; 2020():6706239. PubMed ID: 33101447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.